Article
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
7 Oct 2002
Abstract excerpt
Cisplatin is a chemotherapeutic drug used to treat a variety of cancers. Both intrinsic and acquired resistance to cisplatin, as well as toxicity, limit its effectiveness. Molecular mechanisms that underlie cisplatin resistance are poorly understood. Here we demonstrate that deletion of the yeast CTR1 gene, which encodes a high-affinity copper transporter, results in increased cisplatin resistance and reduced...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
